Artificial Intelligence Is Fastest Growing Segment Fueling The Growth Of Gallbladder Cancer Market


Gallbladder Cancer Market
Gallbladder Cancer Market


Market Overview:

Gallbladder cancer is a rare type of cancer that forms in the gallbladder, a small organ that sits just under the liver. The gallbladder stores and concentrates bile, a fluid that helps digest fats. Early detection of gallbladder cancer is difficult as symptoms are usually vague and non-specific in the early stages.

Market key trends:

One of the key trends in the gallbladder cancer market is the increasing adoption of artificial intelligence. AI helps in early and accurate detection of gallbladder cancer. AI algorithms use CT, MRI, ultrasound images to analyze patterns and identify abnormalities indicative of cancer. This improves diagnostics capabilities. Another trend is the rising focus on targeted drug therapies. Several biopharmaceutical companies are conducting clinical trials to develop targeted therapies for advanced or metastatic gallbladder cancer. Monoclonal antibody drugs and immune checkpoint inhibitors are some newer targeted therapies being researched.

The global Gallbladder Cancer Market Demand is estimated to be valued at US$ 73.6 Mn or Million in 2023 and is expected to exhibit a CAGR of 4.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Segment Analysis
The global gallbladder cancer market is segmented based on diagnosis, treatment, and end user. By diagnosis, the market is categorized into imaging tests and biopsies. The imaging tests segment held the largest share in 2020 as imaging tests are the most effective way to diagnose gallbladder cancer. These tests help identify the size, location, and extent of cancer. The treatment segment is divided into surgery, chemotherapy, radiation therapy, targeted therapy, and immunotherapy. Surgery dominates the segment as it remains the most recommended treatment option. However, the targeted therapy segment is expected to grow at the fastest rate during the forecast period, driven by the introduction of targeted drugs for advanced or metastatic gallbladder cancer. On the basis of end user, the market is classified into hospitals, oncology centers, surgical centers, and others. The hospitals segment accounted for the largest share due to the availability of advanced treatment facilities.

Key Takeaways
The global gallbladder cancer market size is expected to reach US$ 73.6 Mn by 2023, expanding at a CAGR of 4.5% during the forecast period. The increasing prevalence of gallbladder cancer due to changing lifestyle and diet habits is fueling market growth.

Regional analysis: North America dominated the global gallbladder market in 2020 and is expected to continue leading over the forecast period. This can be attributed to availability of advanced healthcare facilities and presence of major market players in the region. Asia Pacific is poised to witness the fastest growth owing to large patient base, increasing healthcare expenditure, and rising awareness about gallbladder cancer.

Key players analysis: Key players operating in the gallbladder cancer market are Eli Lilly and Company, Bristol-Myers Squibb, Roche, Pfizer, Novartis, Merck & Co., Inc., Sanofi, AstraZeneca, AbbVie, and Gilead Sciences. Eli Lilly and Company holds the leading market share with its targeted therapy drug Alimta used in treatment of advanced gallbladder cancer. Read More: https://www.ukwebwire.com/growth-in-the-gallbladder-cancer-market-growth-trends-and-forecast-analysis/

Comments

Popular posts from this blog

Agricultural Micronutrients Market Growth Accelerated By Increasing Need For Improved Soil Fertility

Dairy Alternative Market Expected To Reach USD 26.01 Billion By 2023

Antimicrobial Additives Market Growth Accelerated By Rising Demand From End-Use Industries